Arava Treatment,between Beneficial Action on Joint Inflammation and Side Effects on Liver,Myocardium and Kidney in Experimental Murine Arthritis
作者机构：Pathophysiology DepartmentUniversity of Medicine and Pharmacy“Grigore T.Popa”IasiRomania Internal Medicine ClinicSt.Spiridon HospitalIasiRomania
出 版 物：《Journal of Biomedical Science and Engineering》 (生物医学工程（英文）)
年 卷 期：2014年第7卷第9期
页 面：712-720页
学科分类：1002[医学-临床医学] 100214[医学-肿瘤学] 10[医学]
主 题：ARAVA^(█)(Leflunomide) Rheumatoid Arthritis Side Effects
摘 要：The purpose of the experiment was the follow-up in time of the course of joint inflammation phenomena in laboratory animals (white female adult Wistar rats) by determining particular biological, hematological, radiological, osteodensitometric, immunological and anatomic-pathological parameters and by assessing the effects of Leflunomide (Arava) on the course of the disease. ARAVA®(Leflunomide) is a pyrimidine synthesis inhibitor. The experimental study was conducted for 8 weeks. We have also assessed the side effects of the therapy on their liver, myocardium and kidney. Leflunomide therapy improved the course of the clinical and paraclinical parameters, but it did not cure the condition. The positive results in the joints were accompanied by many histological alterations. The experiment revealed the toxic visceral effects of Leflunomide on the liver, heart and kidney.
维普期刊数据库